Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Biomerica Q4 EPS $(0.09) Up From $(0.10) YoY, Sales $1.12M Up From $1.11M YoY

Author: Benzinga Newsdesk | August 29, 2024 09:06am

Biomerica (NASDAQ:BMRA) reported quarterly losses of $(0.09) per share. This is a 10 percent increase over losses of $(0.10) per share from the same period last year. The company reported $1.12 million in sales this quarter. This is a 0.90 percent increase over sales of $1.11 million the same period last year.

Posted In: BMRA

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist